SteadyMed Ltd.
Preservative-free treprostinil formulations and methods and devices for use with same
Last updated:
Abstract:
This invention provides for a unit dosage form of treprostinil at a dosage of between 0.1 mg/mL and 25 mg/mL in a sterile fluid composition formulated for subcutaneous or intravenous injection, which composition does not comprise an antimicrobial preservative, and methods of reducing irritation, inflammation or a combination thereof at a site of subcutaneous or intravenous infusion of treprostinil in a subject in need thereof.
Status:
Grant
Type:
Utility
Filling date:
15 Nov 2015
Issue date:
28 Apr 2020